Nature reports DeepMind released AlphaGenome 2 for predicting where DNA variants act
Nature reported that DeepMind's AlphaGenome 2 can predict the cell types in which a DNA variant is likely to act.
Nature reported that Google DeepMind has released AlphaGenome 2, an AI model designed to predict the cell types in which genetic variants are likely to act. The article said researchers used the model to reproduce parts of a prior finding about a variant associated with inflammatory bowel disease.
The report describes the model's research potential; it does not establish a clinical use.